Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Current Topics in Medicinal Chemistry|September 11, 2008
Lead optimization of melanin concentrating hormone receptor 1 antagonists with low hERG channel activityAndrew S Judd, Andrew J Souers, Philip R KymOrganic Letters|May 7, 2005
Cascade iminium ion reactions for the facile synthesis of quinolizidines. Concise syntheses of (+/-)-epilupinine and (-)-epimyrtineShawn M Amorde, Andrew S Judd, Stephen F MartinExpert Opinion on Therapeutic Patents|December 22, 2009
Inhibitors of diacylglycerol acyltransferase: a review of 2008 patentsAndrew J King, Andrew S Judd, Andrew J SouersACS Medicinal Chemistry Letters|June 14, 2023
Enantioselective Bioreduction of Medicinally Relevant Nitrogen-Heteroaromatic KetonesWen-Ju Bai, Michelle A Estrada, Jackson A Gartman, et al.Current Topics in Medicinal Chemistry|September 28, 2007
Lead optimization strategies and tactics applied to the discovery of melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Andrew S Judd, John K Lynch, et al.Organic Letters|November 2, 2007
Concise construction of novel bridged bicyclic lactams by sequenced Ugi/RCM/Heck reactionsTimothy P Ribelin, Andrew S Judd, Irini Akritopoulou-Zanze, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Discovery and SAR development of thienopyridones: a class of small molecule AMPK activatorsGang Zhao, Rajesh R Iyengar, Andrew S Judd, et al.Journal of Medicinal Chemistry|March 4, 2005
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesityAndrew J Souers, Ju Gao, Michael Brune, et al.Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesityAndrew J Souers, Ju Gao, Dariusz Wodka, et al.ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-XL InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.Pageof 3